Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Antimicrobial office acting director

Executive Summary

CDER Office of Antimicrobial Drug Products Deputy Director Edward Cox is named acting director effective Aug. 21. Former director Mark Goldberger recently accepted a position in CBER as medical director for emerging and pandemic threat preparedness effective Aug. 20 (1"The Pink Sheet" July 24, 2006, In Brief). Division of Antiviral Drug Products Deputy Director Jeff Murray will serve as acting deputy director of OAP...

You may also be interested in...

...And with FDA

Former Center for Drug Evaluation & Research Office of Antimicrobial Products Director Mark Goldberger is appointed to the newly created position of Emergency & Pandemic Threat Preparedness Medical Director in the Center for Biologics Evaluation & Research, where he will guide development and evaluation of products related to pandemic threats...

Roche/Genentech Keeps Commitment To External Cancer Innovation

Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.

US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials

To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts